UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
Commission File Number: 002-78682
NOTIFICATION OF LATE FILING
|X| Form 10-K |_| Form 20-F |_| Form 11-K
|_| Form 10-Q |_| Form 10-D |_| Form N-SAR
For Period Ended: September 30, 2006
|_| Transition Report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-k
|_| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR
For the Transition Period Ended:__________________
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:
--------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
Applied DNA Sciences, Inc.
--------------------------------------------------------------------------------
Full name of registrant
--------------------------------------------------------------------------------
Former name if applicable
25 Health Sciences Drive, Suite 113
--------------------------------------------------------------------------------
Address of principal executive office
Stony Brook, New York 11790
--------------------------------------------------------------------------------
City, state and zip code
PART II - RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
| (a) The reasons described in reasonable detail in Part III of this form
| could not be eliminated without unreasonable effort or expense;
|
| (b) The subject annual report, semi-annual report, transition report on
| Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
| thereof, will be filed on or before the fifteenth calendar day following
[X] | the prescribed due date; or the subject quarterly report or transition
| report on Form 10-Q or subject distribution report on Form 10-D, or
| portion thereof, will be filed on or before the fifth calendar day
| following the prescribed due date; and
|
| (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
| has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
10-D, N-SAR, N-CSR, or the transition report, or portion thereof, could not be
filed within the prescribed time period.
Applied DNA Sciences, Inc. (the "Company") is filing this Notification of
Late Filing on Form 12b-25 with respect to the Company's Annual Report on Form
10-KSB for the year ended September 30, 2006 (the "Form 10-KSB"). The Company is
unable, without unreasonable effort and expense, to file the Form 10-KSB on a
timely basis due to unforeseen delays in the collection and review of
information and the completion of drafting the necessary responses to items
required to be included in the Form 10-KSB.
The Company is currently working with its independent registered public
accounting firm to finalize the audit of its financial statements for the year
ended September 30, 2006. The Company expects that these activities will be
completed and the Form 10-KSB will be filed no later than January 16, 2007.
PART IV -OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
James A. Hayward (631) 444-6862
---------------- ----------- ------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
|X| Yes |_| No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
|_| Yes |X| No
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
Applied DNA Sciences, Inc.
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Dated: January 3, 2007 By: /s/ JAMES A. HAYWARD
----------------------------
James A. Hayward
Chief Executive Officer